U.S. Healthtech Stock News

Travelers Companies (TRV) has attracted fresh attention after launching its AI Claim Assistant, a voice based service built on OpenAI models that handles auto damage claim calls and related customer interactions. See our latest analysis for Travelers Companies. Those AI efforts come as the share price trades at US$308.64, with a 30 day share price return of 9.43% and a 1 year total shareholder return of 21.35%. This suggests sentiment has been improving. The longer term 5 year total...

Broadstone Net Lease (BNL) is back in focus after revealing two new build to suit projects: an industrial warehouse in Sarasota, Florida, and a retail development in Magnolia, Texas, totaling about US$62.1 million in planned investment. See our latest analysis for Broadstone Net Lease. The new Sarasota and Magnolia projects come on the heels of Broadstone Net Lease’s recent earnings update and dividend declaration, with the share price at US$19.43 and a 30 day share price return of 8.25%,...

Earlier this week, ONEOK reported fourth-quarter 2025 revenue of US$9.07 billion and net income of US$977 million, alongside full-year revenue of US$33.63 billion and net income of US$3.39 billion. Management paired these strong 2025 results and a 4% dividend increase with cautious 2026 guidance, highlighting volume growth but pressure from weaker commodity-related pricing. Next, we’ll examine how ONEOK’s strong 2025 performance but muted 2026 earnings outlook could influence its existing...

Dorman Products (DORM) drew investor attention after issuing 2026 earnings guidance calling for 7% to 9% net sales growth and higher diluted EPS, alongside a sizable goodwill impairment linked to its 2025 results. See our latest analysis for Dorman Products. The 1-day share price return of 1.35% to US$118.12 comes after the 2025 earnings release, goodwill impairment, and 2026 guidance. The 7-day share price return of 8.92% and 90-day share price return of 10.70% suggest momentum has cooled,...

Elanco Animal Health reported past fourth-quarter 2025 sales of US$1,144 million and full-year 2025 sales of US$4.72 billion, but moved from prior net income to a net loss of US$276 million for the quarter and US$232 million for the year. At the same time, Elanco exceeded revenue and adjusted earnings expectations, raised its 2026 innovation revenue outlook, announced the AHV International acquisition, and received USDA approval for Befrena, underscoring how product launches and portfolio...

Adams Diversified Equity Fund (ADX) has drawn fresh attention after reporting full year 2025 results, with revenue of US$32.79 million and net income of US$480.65 million. This provides investors with new data to assess the fund. See our latest analysis for Adams Diversified Equity Fund. The earnings release comes after a period where short term share price moves have been fairly muted, while a 1 year total shareholder return of 25.58% and 5 year total shareholder return of 118.76% point to...

If you are wondering whether Stock Yards Bancorp is attractively priced or just fairly valued at its current level, you are in the right place. The share price closed at US$64.14, with returns of a 7.5% decline over 7 days, a 5.2% decline over 30 days, a 1.6% decline year to date, and a 10.4% decline over 1 year, set against gains of 18.1% over 3 years and 31.9% over 5 years. These mixed returns give investors several entry and exit points to think about, especially if you are weighing...

Watsco (WSO) has given investors a mixed update, pairing softer fourth quarter and full year 2025 results with a 10% increase in its annual dividend to US$13.20 per share. See our latest analysis for Watsco. Following the softer 2025 results and higher dividend, Watsco's recent momentum has been positive, with a 1-month share price return of 8.36% and a 90-day share price return of 20.48%, even as the 1-year total shareholder return is negative 14.86% and the 5-year total shareholder return...

Why BILL Holdings is on investors’ radar today BILL Holdings (BILL) is drawing attention after recent trading left the shares around $44.39, with returns under pressure over the past month, past 3 months, and year. See our latest analysis for BILL Holdings. The recent 1 day share price gain of 1.88% contrasts with a weaker trend, with the 90 day share price return of an 11.49% decline and a 1 year total shareholder return of a 19.58% loss suggesting momentum has been fading. If BILL’s recent...

Genesis Energy stock moves and recent return profile Genesis Energy (GEL) has drawn attention after a recent move in its unit price, prompting investors to take a closer look at how its recent returns line up with the fundamentals disclosed here. Over the past month, the stock shows a 4.6% return, with about 15.8% over the past 3 months and 13.7% year to date. On a 1 year basis, the total return figure stands at 46.8%, while the 3 year and 5 year total returns are 76.4% and approximately 16x...

Stepan (SCL) is back in focus after its latest earnings update, paired with Project Catalyst, a two year cost saving plan that includes plant closures, restructuring charges, and an ongoing dividend increase. See our latest analysis for Stepan. The share price reaction to Project Catalyst and the recent earnings miss has been sharp, with a 7 day share price return of a 24.3% decline and a 1 year total shareholder return showing a 15.12% loss. This points to fading momentum following a...

If you are wondering whether Oshkosh is still fairly priced after its recent run, this article explains what the current share price might be implying about the company’s value. Oshkosh shares recently closed at US$170.02, with returns of 16.3% over the last 30 days, 28.6% year to date and 68.9% over the past year, while the last 7 days showed a 3.1% decline. Recent headlines for Oshkosh have focused on the business and its position in the capital goods sector, which helps shape how...

Rambus (NasdaqGS:RMBS) Senior Vice President and CFO Desmond Lynch has recently sold a significant number of company shares. The transaction extends an ongoing pattern, with insider sales and no insider purchases reported over the past year. Investors may watch this activity closely, as insider trading trends can influence sentiment around the stock. Rambus, trading at $99.66, has seen its share price move in different directions over multiple time frames, including a 2.9% decline over the...

In February 2026, American Homes 4 Rent reported fourth-quarter 2025 sales of US$454.99 million and net income of US$127.29 million, alongside a new US$500 million open-ended share repurchase program and completion of a prior US$300 million buyback tranche. The company is pairing this expanded capital return plan with efforts to address housing affordability, targeting delivery of about 1,900 newly built single-family rental homes in 2026 while balancing development spending with home...

If you are wondering whether Boyd Gaming's current share price reflects its true worth, you are not alone; many investors are asking the same question right now. The stock closed at US$83.42 recently, with returns of 10.4% over 1 year and 43.9% over 5 years, while the shorter term picture shows a 3.2% decline over 7 days and a flat 30 day move of 0.1% decline. Recent headlines around Boyd Gaming have focused on its position in the US gaming and hospitality sector and how it is competing in...

Doximity (NYSE:DOCS) CEO Jeffrey A. Tangney is scheduled to present at the ViVE 2026 conference. The event will take place in Los Angeles, bringing together leaders across digital health. The appearance underscores Doximity's visibility with health systems, clinicians, and investors. Doximity runs a digital platform for medical professionals, connecting physicians, advanced practice clinicians, and health systems. Conferences like ViVE 2026 can be important forums for companies focused on...

Granite Construction: recent performance puts valuation in focus Granite Construction (GVA) has caught investor attention after a strong run over the past year, with the stock showing a 64% 1 year total return and gains in the past 3 months. See our latest analysis for Granite Construction. While the latest share price of $134.46 reflects a small pullback over the past week, the 30 day share price return of 12.4% and 1 year total shareholder return of 63.7% suggest momentum has been building...

Cloudflare launched what it calls the first complete Secure Access Service Edge platform with post-quantum encryption across its services. The company also announced a cybersecurity partnership with Mastercard aimed at protecting critical infrastructure and small businesses with real time, risk driven defenses. Cloudflare, trading on the NYSE under ticker NYSE:NET, sits at the intersection of networking and security. This move pushes more of its product stack into the security spotlight...

Cohen & Steers (CNS) has drawn investor attention after its Board of Directors approved a first quarter 2026 cash dividend of $0.67 per share, up from $0.62, payable on March 19. See our latest analysis for Cohen & Steers. Despite the higher dividend, Cohen & Steers’ recent trading has been mixed, with a 30-day share price return of 4.35% and a year to date share price return of 4.97%. However, the 1-year total shareholder return is a 21.13% decline, suggesting only modest momentum after a...

In February 2026, FulcrumAir announced a new multi-year partnership with Preformed Line Products to co-develop next-generation robotic systems for overhead power line construction, targeting improved efficiency, safety, and reliability for utilities worldwide. This expanded collaboration builds on earlier joint products like the LineSpider and LineFly robots, highlighting how automation could reshape how utilities build and maintain critical grid infrastructure. Next, we will examine how...

Disc Medicine stock moves after recent trading swings Disc Medicine (IRON) has seen sharp share price swings recently, including a negative 1 day move and gains over the past week, drawing attention to how the market is currently reacting to its hematology focused pipeline. See our latest analysis for Disc Medicine. Those recent swings come after a 30 day share price return of a 16.74% decline and a 90 day share price return of a 28.64% decline, even as the 1 year total shareholder return of...

Colgate-Palmolive (NYSE:CL) has started executing its 2030 Strategic Plan, with a focus on global brand strength, product innovation grounded in scientific research, and broader demand generation. The company is rolling out advanced digital tools and AI across its supply chain and organization as part of this multi-year plan. The plan is intended to reshape how Colgate-Palmolive competes in oral care, personal care, home care, and pet nutrition categories worldwide. For investors watching...

Sotera Health reported its fourth-quarter and full-year 2025 results on February 24, 2026, with revenue rising to US$303.44 million for the quarter and US$1.16 billion for the year, alongside higher net income and earnings per share. The company also issued 2026 revenue guidance of US$1.23 billion to US$1.25 billion and marked its 20th consecutive year of revenue growth, underscoring consistent demand for its sterilization and lab testing services. Next, we’ll examine how Sotera Health’s...

Energy Recovery (ERII) shares are in focus after the company released fourth quarter and full year 2025 earnings, highlighting quarterly net income and earnings per share growth alongside slightly softer annual sales. See our latest analysis for Energy Recovery. Despite the latest earnings update showing firmer quarterly profitability, the share price has come under pressure recently, with a 7 day share price return of 35.78% decline and a 1 year total shareholder return of 30.28% decline...